Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Rat oral LD50 of phenyl salicylate is 3000 mg/kg bw.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Referenceopen allclose all

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Species:
rabbit
Strain:
not specified
Sex:
not specified
Route of administration:
oral: unspecified
Vehicle:
not specified
Key result
Sex:
not specified
Dose descriptor:
LDLo
Effect level:
3 000 mg/kg bw
Other findings:
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Interpretation of results:
GHS criteria not met
Remarks:
CLP criteria not met
Conclusions:
Rabbit, oral, LDLo = 3000 mg/kg bw.
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Species:
rat
Strain:
not specified
Sex:
not specified
Route of administration:
oral: unspecified
Vehicle:
not specified
Key result
Sex:
not specified
Dose descriptor:
LD50
Effect level:
3 000 mg/kg bw
Based on:
not specified
Interpretation of results:
other: CLP Regulation criteria not met.
Conclusions:
Rat, oral LD50 of phenyl salicylate is 3000 mg/kg bw.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
3 000 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

Acute toxicity - oral route

Overall, available data are conclusive but not sufficient for the classification of the substance.

Specific target organ toxicity after single exposure

In the safety data sheet of the U.S. Pharmacopeial convention the substance, identified as Salicylic acid phenyl ester, is classified (according to GHS) for specific target organ toxicity, single exposure Category 3, respiratory tract irritation. In section 11, only generic information is reported: "Respiratory tract irritation.". Overall, available information is inconclusive for the classification of the substance.